Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | CRGX | Common Stock | 73.7K | Nov 9, 2023 | By Samsara BioCapital, L.P. | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | CRGX | Series Seed convertible preferred stock | Nov 9, 2023 | Common Stock | 663K | By Samsara BioCapital, L.P. | F1, F2, F3 | |||||||
holding | CRGX | Series A-1 convertible preferred stock | Nov 9, 2023 | Common Stock | 884K | By Samsara BioCapital, L.P. | F1, F2, F3 | |||||||
holding | CRGX | Series A-2 convertible preferred stock | Nov 9, 2023 | Common Stock | 1.83M | By Samsara BioCapital, L.P. | F1, F2, F3 |
Id | Content |
---|---|
F1 | Reflects a 1-for-13.5685 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement on November 3, 2023. |
F2 | Shares are held by Samsara BioCapital LP ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein. |
F3 | Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock will automatically convert into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date. |